[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

RLMD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.50%

Insider Buying (Last 12 Months): $147,825.00

Insider Selling (Last 12 Months): $0.00

Relmada Therapeutics Insider Trading History Chart

Relmada Therapeutics Share Price & Price History

^$2.51

▼ -0.23 (-8.39%)

As of 11/29/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

Relmada Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/23/2023	Cedric O'gorman	Insider	Buy	10,000	$3.18	$31,800.00	10,121
12/8/2022	Sergio Traversa	CEO	Buy	55,250	$2.10	$116,025.00	144,024
6/30/2022	Sergio Traversa	CEO	Sell	16,012	$19.13	$306,309.56	88,774
4/4/2022	Paul Edward Kelly	Director	Sell	10,000	$30.04	$300,400.00	187,295
9/22/2021	Charles J. Casamento	Director	Sell	6,600	$29.00	$191,400.00
7/15/2021	Charles J. Casamento	Director	Sell	3,300	$31.54	$104,082.00	5,854
6/1/2021	Charles J. Casamento	Director	Sell	3,000	$33.34	$100,020.00	9,430
4/1/2021	Charles J. Casamento	Director	Sell	3,000	$35.43	$106,290.00	14,641
3/10/2021	Maged Shenouda	CFO	Sell	2,373	$35.11	$83,316.03	12,228
3/9/2021	Paul Edward Kelly	Director	Sell	5,000	$35.71	$178,550.00	172,295
3/9/2021	Sergio Traversa	CEO	Sell	7,017	$35.65	$250,156.05	98,774
3/8/2021	Maged Shenouda	CFO	Sell	100	$35.00	$3,500.00	12,228
2/10/2021	Maged Shenouda	CFO	Sell	2,410	$35.20	$84,832.00	13,600
2/10/2021	Sergio Traversa	CEO	Sell	1,930	$35.28	$68,090.40	99,980
2/8/2021	Maged Shenouda	CFO	Sell	3,603	$35.04	$126,249.12	13,600
2/8/2021	Paul Edward Kelly	Director	Sell	1,500	$35.04	$52,560.00	165,864
2/8/2021	Sergio Traversa	CEO	Sell	3,313	$35.03	$116,054.39	99,980
2/3/2021	Maged Shenouda	CFO	Sell	3,200	$35.04	$112,128.00	5,428
2/3/2021	Sergio Traversa	CEO	Sell	3,278	$35.07	$114,959.46	92,052
2/1/2021	Charles J. Casamento	Director	Sell	3,000	$33.63	$100,890.00
1/27/2021	Maged Shenouda	CFO	Sell	3,000	$31.93	$95,790.00	5,228
1/27/2021	Paul Edward Kelly	Director	Sell	5,000	$32.46	$162,300.00	152,295
1/26/2021	Sergio Traversa	CEO	Sell	600	$35.15	$21,090.00	79,563
1/25/2021	Maged Shenouda	CFO	Sell	1,280	$35.27	$45,145.60	6,228
1/25/2021	Paul Edward Kelly	Director	Sell	1,300	$35.27	$45,851.00	151,380
1/22/2021	Maged Shenouda	CFO	Sell	2,113	$35.55	$75,117.15	6,228
1/22/2021	Paul Edward Kelly	Director	Sell	2,100	$3,042.03	$6,388,263.00	151,380
1/22/2021	Sergio Traversa	CEO	Sell	2,170	$35.58	$77,208.60	79,563

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Relmada Therapeutics (NASDAQ:RLMD)

53.50% of Relmada Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Relmada Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/17/2023	Jacobs Levy Equity Management Inc.	125,846	$0.38M	0.0%	N/A	0.418%
11/15/2023	GSA Capital Partners LLP	195,415	$0.59M	0.1%	-28.0%	0.649%
11/14/2023	Schonfeld Strategic Advisors LLC	109,310	$0.33M	0.0%	N/A	0.363%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	87,153	$0.26M	0.0%	-16.6%	0.290%
11/13/2023	Mariner LLC	23,253	$70K	0.0%	-24.7%	0.077%
11/13/2023	LPL Financial LLC	12,960	$39K	0.0%	N/A	0.043%
11/13/2023	Acadian Asset Management LLC	1,172,723	$3.51M	0.0%	-4.0%	3.896%
11/13/2023	Silverarc Capital Management LLC	100,000	$0.30M	0.1%	N/A	0.332%
11/9/2023	Citigroup Inc.	99,523	$0.30M	0.0%	-16.6%	0.331%
11/9/2023	UBS Group AG	125,688	$0.38M	0.0%	+27.0%	0.418%
11/6/2023	Parsons Capital Management Inc. RI	974,082	$2.92M	0.2%	+11.5%	3.236%
11/6/2023	Guild Investment Management Inc.	205,300	$0.62M	1.0%	+84.0%	0.682%
10/27/2023	TD Asset Management Inc	25,000	$75K	0.0%	+100.0%	0.083%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	259,009	$0.78M	0.0%	-23.6%	0.860%
10/24/2023	Bank of New York Mellon Corp	36,719	$0.11M	0.0%	-53.8%	0.122%
10/24/2023	Stratos Wealth Partners LTD.	16,000	$48K	0.0%	N/A	0.053%
9/21/2023	Barclays PLC	145,999	$0.36M	0.0%	+884.0%	0.485%
8/15/2023	XTX Topco Ltd	10,767	$26K	0.0%	-87.5%	0.036%
8/15/2023	Y Intercept Hong Kong Ltd	42,574	$0.11M	0.0%	N/A	0.141%
8/15/2023	Goldman Sachs Group Inc.	162,347	$0.40M	0.0%	-18.8%	0.539%
8/15/2023	RBF Capital LLC	194,074	$0.48M	0.0%	N/A	0.645%
8/14/2023	PDT Partners LLC	31,741	$78K	0.0%	-54.2%	0.105%
8/14/2023	Ergoteles LLC	27,100	$67K	0.0%	N/A	0.090%
8/14/2023	State Street Corp	129,429	$0.32M	0.0%	-76.5%	0.430%
8/11/2023	Renaissance Technologies LLC	132,772	$0.33M	0.0%	-57.6%	0.441%
8/11/2023	BlackRock Inc.	605,254	$1.49M	0.0%	-67.1%	2.011%
8/11/2023	The Manufacturers Life Insurance Company	20,343	$50K	0.0%	-18.7%	0.068%
8/11/2023	Geode Capital Management LLC	234,362	$0.58M	0.0%	-53.3%	0.779%
8/11/2023	Northern Trust Corp	47,450	$0.12M	0.0%	-77.4%	0.158%
8/10/2023	Bedel Financial Consulting Inc.	10,000	$25K	0.0%	N/A	0.033%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	338,945	$0.83M	0.0%	+17.3%	1.126%
8/10/2023	Charles Schwab Investment Management Inc.	12,505	$31K	0.0%	-83.1%	0.042%
8/10/2023	Citigroup Inc.	119,318	$0.29M	0.0%	N/A	0.396%
8/9/2023	AdvisorShares Investments LLC	112,898	$0.28M	0.1%	+8.4%	0.375%
8/7/2023	Tortoise Investment Management LLC	19,176	$47K	0.0%	+52.7%	0.064%
8/4/2023	Parsons Capital Management Inc. RI	873,312	$2.15M	0.2%	+20.9%	2.901%
8/3/2023	Barclays PLC	145,999	$0.36M	0.0%	+884.0%	0.485%
8/3/2023	Bank of New York Mellon Corp	79,428	$0.20M	0.0%	-48.3%	0.264%
7/20/2023	Guild Investment Management Inc.	111,550	$0.27M	0.4%	+7.4%	0.371%
6/1/2023	Prelude Capital Management LLC	16,700	$38K	0.0%	N/A	0.055%
5/18/2023	JPMorgan Chase & Co.	20,981	$47K	0.0%	+35.3%	0.070%
5/16/2023	Spotlight Asset Group Inc.	20,000	$0.14M	0.1%	N/A	0.066%
5/16/2023	State Street Corp	551,096	$1.25M	0.0%	+11.2%	1.831%
5/16/2023	Geode Capital Management LLC	502,343	$1.14M	0.0%	+3.3%	1.669%
5/16/2023	AQR Capital Management LLC	36,991	$84K	0.0%	+21.9%	0.123%
5/15/2023	Palo Alto Investors LP	542,100	$1.23M	0.1%	N/A	1.801%
5/15/2023	Two Sigma Advisers LP	357,600	$0.81M	0.0%	+10.7%	1.188%
5/15/2023	Two Sigma Investments LP	404,275	$0.91M	0.0%	-23.3%	1.343%
5/15/2023	Deutsche Bank AG	254,742	$0.58M	0.0%	+6.5%	0.846%
5/15/2023	Price T Rowe Associates Inc. MD	178,440	$0.40M	0.0%	-4.8%	0.593%
5/15/2023	RTW Investments LP	2,131,835	$4.82M	0.1%	+3.1%	7.083%
5/15/2023	XTX Topco Ltd	86,267	$0.20M	0.0%	-33.3%	0.287%
5/12/2023	Renaissance Technologies LLC	313,175	$0.71M	0.0%	+43.8%	1.040%
5/12/2023	BlackRock Inc.	1,838,417	$4.16M	0.0%	-1.3%	6.108%
5/12/2023	Bank of America Corp DE	37,334	$84K	0.0%	+125.4%	0.124%
5/12/2023	Sei Investments Co.	36,969	$84K	0.0%	-63.5%	0.123%
5/12/2023	Dimensional Fund Advisors LP	55,568	$0.13M	0.0%	-8.4%	0.185%
5/12/2023	Charles Schwab Investment Management Inc.	73,915	$0.17M	0.0%	+20.4%	0.246%
5/11/2023	Acadian Asset Management LLC	1,221,399	$2.76M	0.0%	+11.0%	4.058%
5/11/2023	FMR LLC	89,478	$0.20M	0.0%	+6.8%	0.297%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	109,959	$0.25M	0.0%	-7.3%	0.365%
5/9/2023	Tortoise Investment Management LLC	12,561	$28K	0.0%	+65.6%	0.042%
5/9/2023	AdvisorShares Investments LLC	104,140	$0.24M	0.1%	+28.0%	0.346%
5/9/2023	Bank of New York Mellon Corp	153,503	$0.35M	0.0%	-17.5%	0.510%
5/4/2023	Barclays PLC	14,838	$33K	0.0%	+102.5%	0.049%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	288,946	$0.65M	0.0%	+3.4%	0.960%
5/2/2023	Sargent Investment Group LLC	14,317	$34K	0.0%	N/A	0.048%
4/27/2023	Tiedemann Advisors LLC	30,215	$68K	0.0%	+49.5%	0.100%
4/18/2023	Guild Investment Management Inc.	103,900	$0.24M	0.4%	N/A	0.345%
4/17/2023	Parsons Capital Management Inc. RI	722,166	$1.63M	0.1%	+45.5%	2.399%
2/28/2023	Voya Investment Management LLC	10,752	$38K	0.0%	-47.1%	0.036%
2/16/2023	Alliancebernstein L.P.	30,400	$0.11M	0.0%	+69.8%	0.101%
2/16/2023	Point72 Middle East FZE	15,517	$54K	0.0%	N/A	0.052%
2/15/2023	Schonfeld Strategic Advisors LLC	75,300	$0.26M	0.0%	-50.0%	0.250%
2/15/2023	Squarepoint Ops LLC	35,281	$0.12M	0.0%	N/A	0.117%
2/15/2023	Tang Capital Management LLC	100,000	$0.35M	0.1%	-75.0%	0.332%
2/15/2023	Millennium Management LLC	1,061,774	$3.71M	0.0%	-5,364.1%	3.527%
2/15/2023	Morgan Stanley	488,739	$1.71M	0.0%	+67.0%	1.624%
2/15/2023	Mariner LLC	41,080	$0.14M	0.0%	N/A	0.136%
2/15/2023	AQR Capital Management LLC	30,343	$0.11M	0.0%	N/A	0.101%
2/15/2023	Boothbay Fund Management LLC	12,792	$45K	0.0%	N/A	0.042%
2/14/2023	Price T Rowe Associates Inc. MD	187,459	$0.65M	0.0%	-4.6%	0.623%
2/14/2023	Two Sigma Investments LP	527,162	$1.84M	0.0%	+916.0%	1.751%
2/14/2023	Arrowstreet Capital Limited Partnership	21,420	$75K	0.0%	N/A	0.071%
2/14/2023	Engineers Gate Manager LP	45,424	$0.16M	0.0%	N/A	0.151%
2/13/2023	Charles Schwab Investment Management Inc.	61,410	$0.21M	0.0%	-12.9%	0.204%
2/13/2023	Renaissance Technologies LLC	217,810	$0.76M	0.0%	N/A	0.724%
2/13/2023	The Manufacturers Life Insurance Company	25,037	$89K	0.0%	-17.7%	0.083%
2/13/2023	Geode Capital Management LLC	486,251	$1.70M	0.0%	-0.9%	1.615%
2/13/2023	GSA Capital Partners LLP	122,590	$0.43M	0.1%	N/A	0.407%
2/13/2023	JPMorgan Chase & Co.	15,503	$54K	0.0%	-120.6%	0.052%
2/10/2023	Bank of America Corp DE	16,560	$58K	0.0%	+19.4%	0.055%
2/10/2023	Sei Investments Co.	101,345	$0.35M	0.0%	N/A	0.337%
2/10/2023	AXQ Capital LP	12,483	$44K	0.0%	N/A	0.041%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	118,651	$0.41M	0.0%	+245.6%	0.394%
2/10/2023	HRT Financial LP	158,320	$0.55M	0.0%	N/A	0.526%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	279,415	$0.98M	0.0%	+287.9%	0.928%
2/9/2023	Chicago Partners Investment Group LLC	14,310	$57K	0.0%	N/A	0.048%
2/9/2023	Dimensional Fund Advisors LP	60,633	$0.21M	0.0%	-69.5%	0.201%
2/9/2023	Cowen AND Company LLC	64,011	$0.22M	0.0%	-70.4%	0.213%

Data available starting January 2016

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.

Today's Range

Now: $2.51

$2.45

$2.80

50 Day Range

MA: $3.03

$2.51

$3.53

52 Week Range

Now: $2.51

$1.81

$4.89

Volume

225,736 shs

Average Volume

197,295 shs

Market Capitalization

$75.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.16

Who are the company insiders with the largest holdings of Relmada Therapeutics?: Relmada Therapeutics' top insider shareholders include:
Paul Edward Kelly (Director)
Sergio Traversa (CEO)
Cedric O'gorman (Insider)
Learn More about top insider investors at Relmada Therapeutics.
Who are the major institutional investors of Relmada Therapeutics?: Relmada Therapeutics' top institutional shareholders include:
Acadian Asset Management LLC — 3.90%
Parsons Capital Management Inc. RI — 3.24%
Mirae Asset Global Investments Co. Ltd. — 0.86%
Guild Investment Management Inc. — 0.68%
GSA Capital Partners LLP — 0.65%
Group One Trading L.P. — 0.00%
Learn More about top institutional investors of Relmada Therapeutics stock.
Which major investors are selling Relmada Therapeutics stock?: Within the previous quarter, RLMD stock was sold by these institutional investors:
Group One Trading L.P.
Mirae Asset Global Investments Co. Ltd.
GSA Capital Partners LLP
Acadian Asset Management LLC
Bank of New York Mellon Corp
Citigroup Inc.
Connor Clark & Lunn Investment Management Ltd.
Wolverine Trading LLC
Which major investors are buying Relmada Therapeutics stock?: Within the last quarter, RLMD stock was purchased by institutional investors including:
Jacobs Levy Equity Management Inc.
Schonfeld Strategic Advisors LLC
Parsons Capital Management Inc. RI
Silverarc Capital Management LLC
Guild Investment Management Inc.
UBS Group AG
Stratos Wealth Partners LTD.
LPL Financial LLC
During the last year, these company insiders have bought Relmada Therapeutics stock:
Paul Edward Kelly (Director)
Sergio Traversa (CEO)
Learn More investors buying Relmada Therapeutics stock.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

RLMD Insider Trading

Relmada Therapeutics Insider Trading History Chart

Relmada Therapeutics Share Price & Price History

Relmada Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Relmada Therapeutics (NASDAQ:RLMD)

Institutional Buying and Selling by Quarter

Relmada Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Relmada Therapeutics?

Who are the major institutional investors of Relmada Therapeutics?

Which major investors are selling Relmada Therapeutics stock?

Which major investors are buying Relmada Therapeutics stock?